Results 201 to 210 of about 12,265,574 (365)
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta +21 more
semanticscholar +1 more source
ABSTRACT Ischemic stroke is frequently associated with symptomatic intracranial atherosclerotic stenosis (sICAS), is a leading cause of global disability and mortality. Current guidelines recommend dual antiplatelet and intensive statin therapies. Proprotein convertase subtilisin 9/kexin type 9 (PCSK9) inhibitors have emerged as a potent lipid‐lowering
Chao Zhao +5 more
wiley +1 more source
Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: A pilot study [PDF]
Carolina De Ciuceis +11 more
openalex +1 more source
Antihypertensive treatment in young adults and cardiovascular risk: a population-based cohort study. [PDF]
Rea F, Morabito G, Corrao G, Mancia G.
europepmc +1 more source
3894Predictors of non-adherence to antihypertensive treatment: insights from liquid chromatography tandem mass spectrometry based analysis [PDF]
Pankaj Gupta +13 more
openalex +1 more source
ABSTRACT Circadian rhythms orchestrate cardiovascular physiology by regulating immune and inflammatory pathways. Disruption of these rhythms profoundly alters vascular homeostasis, thereby promoting the onset and progression of cardiovascular diseases (CVD).
Tian Zhang +22 more
wiley +1 more source
Correction: The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. [PDF]
Sheppard JP +11 more
europepmc +1 more source
Abstract Background Although previous experimental studies showed that metabolic acidosis promoted muscle catabolism and impaired protein synthesis, few epidemiological studies reported an independent association between serum bicarbonate levels and muscle atrophy in patients with chronic kidney disease (CKD).
Nobuhisa Morimoto +13 more
wiley +1 more source
Impact of Antihypertensive Treatment Adherence on Premature Mortality over Seven Years: A Follow-Up Investigation. [PDF]
Elehamer NMK +4 more
europepmc +1 more source

